# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001628280-22-025519
Filing Date
2022-09-27
Accepted
2022-09-27 07:53:07
Documents
42
Period of Report
2022-09-27
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | xfor-20220927.htm iXBRL | 8-K | 43254
2 | EX-99.1 | ex991xforpressrelease.htm | EX-99.1 | 13021
3 | EX-99.2 | ex992xforinvestordeck.htm | EX-99.2 | 25165
7 |  | ex991xforpressrelease001.jpg | GRAPHIC | 219306
8 |  | ex991xforpressrelease002.jpg | GRAPHIC | 264150
9 |  | ex991xforpressrelease003.jpg | GRAPHIC | 299769
10 |  | ex991xforpressrelease004.jpg | GRAPHIC | 39047
11 |  | ex992xforinvestordeck001.jpg | GRAPHIC | 90662
12 |  | ex992xforinvestordeck002.jpg | GRAPHIC | 193877
13 |  | ex992xforinvestordeck003.jpg | GRAPHIC | 50684
14 |  | ex992xforinvestordeck004.jpg | GRAPHIC | 135994
15 |  | ex992xforinvestordeck005.jpg | GRAPHIC | 105813
16 |  | ex992xforinvestordeck006.jpg | GRAPHIC | 87373
17 |  | ex992xforinvestordeck007.jpg | GRAPHIC | 102642
18 |  | ex992xforinvestordeck008.jpg | GRAPHIC | 71464
19 |  | ex992xforinvestordeck009.jpg | GRAPHIC | 85010
20 |  | ex992xforinvestordeck010.jpg | GRAPHIC | 107267
21 |  | ex992xforinvestordeck011.jpg | GRAPHIC | 83662
22 |  | ex992xforinvestordeck012.jpg | GRAPHIC | 78794
23 |  | ex992xforinvestordeck013.jpg | GRAPHIC | 97881
24 |  | ex992xforinvestordeck014.jpg | GRAPHIC | 87276
25 |  | ex992xforinvestordeck015.jpg | GRAPHIC | 91235
26 |  | ex992xforinvestordeck016.jpg | GRAPHIC | 95307
27 |  | ex992xforinvestordeck017.jpg | GRAPHIC | 85151
28 |  | ex992xforinvestordeck018.jpg | GRAPHIC | 86698
29 |  | ex992xforinvestordeck019.jpg | GRAPHIC | 91651
30 |  | ex992xforinvestordeck020.jpg | GRAPHIC | 88128
31 |  | ex992xforinvestordeck021.jpg | GRAPHIC | 107953
32 |  | ex992xforinvestordeck022.jpg | GRAPHIC | 109956
33 |  | ex992xforinvestordeck023.jpg | GRAPHIC | 77487
34 |  | ex992xforinvestordeck024.jpg | GRAPHIC | 95289
| Complete submission text file | 0001628280-22-025519.txt |  | 4557393

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | xfor-20220927.xsd | EX-101.SCH | 1908
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | xfor-20220927_lab.xml | EX-101.LAB | 25948
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | xfor-20220927_pre.xml | EX-101.PRE | 13681
36 | EXTRACTED XBRL INSTANCE DOCUMENT | xfor-20220927_htm.xml | XML | 11883

Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38295 | Film No.: 221267281
SIC: 2836 Biological Products, (No Diagnostic Substances)